BR9804395A - Long-acting, injectable pharmaceutical composition based on a tetracycline. - Google Patents

Long-acting, injectable pharmaceutical composition based on a tetracycline.

Info

Publication number
BR9804395A
BR9804395A BR9804395-1A BR9804395A BR9804395A BR 9804395 A BR9804395 A BR 9804395A BR 9804395 A BR9804395 A BR 9804395A BR 9804395 A BR9804395 A BR 9804395A
Authority
BR
Brazil
Prior art keywords
long
acting
tetracycline
pharmaceutical composition
pharmaceutically acceptable
Prior art date
Application number
BR9804395-1A
Other languages
Portuguese (pt)
Inventor
Jan Wolff
Mamoru Rodolfo Hojo
Original Assignee
Hoechst Roussel Vet S A Brasil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Vet S A Brasil filed Critical Hoechst Roussel Vet S A Brasil
Priority to BR9804395-1A priority Critical patent/BR9804395A/en
Publication of BR9804395A publication Critical patent/BR9804395A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçãO FARMACêUTICA INJETáVEL, DE LONGA AçãO, à BASE DE UMA TETRACICLINA"<D>. A presente invenção refere-se uma composição farmacêutica injetável, de longa ação, à base de um antimicrobiano do grupo das tetraciclinas, compreendendo, acondicionada em um único frasco, uma associação de um antimicrobiano do grupo das tetraciclinas com um antiinflamatório não-hormonal, em um excipiente de longa ação adequado, pronta para o uso, a dita composição sendo caracterizada pelo fato de que contém, como excipiente de longa ação, um excipiente de longa ação à base de óxido de magnésio ou cloreto de magnésio, polietilenoglicol 400 ou polietilenoglicol 200, monoetanolamina ou outras bases farmaceuticamente aceitáveis, formaldeído sulfoxilato de sódio ou outros agentes antioxidantes farmaceuticamente aceitáveis ou associações antioxidantes farmaceuticamente aceitáveis, tais como por exemplo formaldeído sulfoxilato de sódio com EDTA, e água desmineralizada ou osmotizada. A composição é utilizável para controle de germes Gram-positivos e Gram-negativos, algumas espécies de micoplasmas, protozoários e rickettsias, em bovinas, suínos, ovinos e caprinos, e é aplicável por via subcutânea (SC), intramuscular (IM) ou endovenosa (EV).Invention Patent: <B> "LONG-TERM INJECTION PHARMACEUTICAL COMPOSITION, BASED ON A TETRACYCLINE" <D>. The present invention relates to a long-acting injectable pharmaceutical composition based on an antimicrobial from the tetracycline group, comprising, packaged in a single bottle, an association of an antimicrobial from the tetracycline group with a non-hormonal anti-inflammatory, in a suitable long-acting excipient, ready for use, said composition being characterized by the fact that it contains, as a long-acting excipient, a long-acting excipient based on magnesium oxide or magnesium chloride, polyethylene glycol 400 or polyethylene glycol 200 , monoethanolamine or other pharmaceutically acceptable bases, sodium formaldehyde sulfoxylate or other pharmaceutically acceptable antioxidant agents or pharmaceutically acceptable antioxidant combinations, such as for example sodium formaldehyde sulfoxylate with EDTA, and demineralized or osmotized water. The composition is usable to control Gram-positive and Gram-negative germs, some species of mycoplasmas, protozoa and rickettsiae, in cattle, pigs, sheep and goats, and is applicable subcutaneously (SC), intramuscularly (IM) or intravenously (EV).

BR9804395-1A 1998-11-04 1998-11-04 Long-acting, injectable pharmaceutical composition based on a tetracycline. BR9804395A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9804395-1A BR9804395A (en) 1998-11-04 1998-11-04 Long-acting, injectable pharmaceutical composition based on a tetracycline.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR9804395-1A BR9804395A (en) 1998-11-04 1998-11-04 Long-acting, injectable pharmaceutical composition based on a tetracycline.

Publications (1)

Publication Number Publication Date
BR9804395A true BR9804395A (en) 2000-06-06

Family

ID=4070828

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9804395-1A BR9804395A (en) 1998-11-04 1998-11-04 Long-acting, injectable pharmaceutical composition based on a tetracycline.

Country Status (1)

Country Link
BR (1) BR9804395A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084802B2 (en) 2010-05-12 2015-07-21 Rempex Pharmaceuticals, Inc. Tetracycline compositions

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9084802B2 (en) 2010-05-12 2015-07-21 Rempex Pharmaceuticals, Inc. Tetracycline compositions
US9278105B2 (en) 2010-05-12 2016-03-08 Rempex Pharmaceuticals, Inc. Tetracycline compositions
US9744179B2 (en) 2010-05-12 2017-08-29 Rempex Pharmaceuticals, Inc. Tetracycline compositions
US11944634B2 (en) 2010-05-12 2024-04-02 Melinta Subsidiary Corp. Tetracycline compositions

Similar Documents

Publication Publication Date Title
NZ504986A (en) Erythromycin and azalide derivatives and pharmaceutical compositions thereof, useful as antibacterial agents and antoprotozoa agents
ES2178000T3 (en) COMPOSITIONS AND METHODS TO TREAT INFECTIONS USING INDOLICIDINE ANALOGS.
BRPI0017013B8 (en) azalide antibiotic composition and method for obtaining it
ES2157027T3 (en) OXAZOLIDINONES REPLACED AND ITS USE AS ANTIBACTERIAL PHARMACOS.
ECSP034438A (en) NEW PEPTIDES AS INHIBITORS OF NS-3-SERINA PROTEASA OF THE HEPATITIS C VIRUS
ES2150050T3 (en) POLYACARIDS INTEGRATED WITH ANTIOXIDANTS AND ITS USE.
AR008444A1 (en) EMPLOYMENT OF LEPTINE ANTAGONISTS FOR THE TREATMENT OF INSULIN RESISTANCE IN TYPE II DIABETES
AR041913A1 (en) CONTROLLED RELEASE DEPOSIT FORMULATIONS
DE69923471D1 (en) INJECTABLE PROPOFOL FORMULATIONS
BRPI0410884A (en) feed composition for use in a pet, and method for weight control in a pet
PA8489501A1 (en) CETOLID ANTIBIOTICS
ES2055406T3 (en) COMPOSITION FOR THE TREATMENT OF INFLAMMATION.
AR043603A1 (en) INJECTABLE COMPOSITIONS FOR INTRAMUSCULAR USE CONTAINING ESTERES OF TESTOSTERONE AND A VEHICLE THAT INCLUDES RICHINE OIL AND A WATER
BR0207978A (en) N-but-3enyl norbuprenorphine and methods of use
PA8485601A1 (en) AZALIDAS OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS.
CO5011078A1 (en) ORAL COMPOSITION THAT INCLUDES A CASEINE GLICOMACROPEPTIDE THAT HAS ANTIPLACY AND ANTICARIES ACTIVITY AND METHOD OF PREPARING IT
BR0009524A (en) Use of a compound, and, pharmaceutical or veterinary composition
BR0315513A (en) Injectable pharmaceutical composition, process for preparing pharmaceutical composition, and use of cefquinome in a vehicle with prolonged release
BR9408305A (en) Compound pharmaceutical composition processes for the treatment of AIDS and HIV infection for the preparation of HIV infection and for inhibition of HIV protease and combination of compounds
ES2072092T3 (en) STABILIZATION OF THYLENE COMPOSITIONS.
DE69902526D1 (en) IMPROVING THE ANTIBACTERIAL EFFECT OF OXAZOLIDINONE BY ARGININE DERIVATIVES
AR247984A1 (en) Anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent
BR9804395A (en) Long-acting, injectable pharmaceutical composition based on a tetracycline.
GT200100063A (en) THE USE OF COMPOSITIONS BASED ON ANTIBIOTICS OF AZALIDES TO TREAT OR PREVENT A BACTERIAL INFECTION OR PROTOZOARY IN MAMMALS
CO4810296A1 (en) DOUBLE COMPONENT ANTI-PLATE DENTRIFY COMPOSITION

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM O ARTIGO 37 COM BASE NOS ARTIGOS 8O E 13 DA LPI

B12B Appeal: appeal against refusal